Darifenacin

Back to search

Molecule Structure

Scientific Name

Darifenacin

Description of the Drug

Darifenacin is an M3 muscarinic receptor blocker used to treat urinary incontinence.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00496

Brand Name(s)

Not Available

Company Owner(s)

Allergan Pharmaceuticals International Ltd, Cipla Ltd, Alembic Pharmaceuticals Ltd, Jubilant Generics Ltd, Macleods Pharmaceuticals Ltd, Polygen Pharmaceuticals Inc, Xiromed Pharma Espana Sl, Aurobindo Pharma Ltd, Anchen Pharmaceuticals Inc, Torrent Pharmaceuticals Ltd

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Muscarinic acetylcholine receptor M2 SINGLE PROTEIN ANTAGONIST CHEMBL211
Muscarinic acetylcholine receptor M3 SINGLE PROTEIN ANTAGONIST CHEMBL245

Unichem Links

SureChEMBL SCHEMBL56574
PharmGKB PA164774901
Human Metabolome Database HMDB0014639
DrugBank DB00496
PubChem: Thomson Pharma 14856314
PubChem 444031
Mcule MCULE-4616748439
LINCS LSM-5995
Nikkaji J615.836F
BindingDB 50109647
EPA CompTox Dashboard DTXSID2048290
DrugCentral 784
ChemicalBook CB1506695
Guide to Pharmacology 321 319
rxnorm ENABLEX DARIFENACIN HYDROBROMIDE DARIFENACIN
ChEBI 391960
ZINC ZINC000001996117